Challenge
A major pharmaceutical company with a deep legacy in Oncology and a strong commitment to delivering better patient experiences recognized that it was imperative to go beyond the direct influence of HCPs. The company needed to fill gaps in knowledge to understand how to win across all Oncology stakeholders, not just with clinicians, given the complex realities of Oncology care today. Therefore, they sought to deeply understand the needs and perspectives of non-prescribing healthcare ecosystem (access) stakeholders, with roles as purchasers, payers, patient advocates, and policymakers.
Approach
To advance perceptions of the Oncology franchise, it was important to establish a baseline of current perceptions and understand which manufacturers were considered best-in-class by ecosystem stakeholders, and why. HawkPartners followed a three-phased approach to developing the access strategy.